Effects of doxycycline on development of changes in histomorphometric parameters of bones induced by bilateral ovariectomy in rats

Polish Journal of Pharmacology

Volumn 55, Issue 3, 2003, Pages 433-441

  Folwarczna, Joanna ^a   Pytlik, Maria ^a   Janiec, Waldemar ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Doxycycline; Osteoporosis; Ovariectomy; Rat

Indexed keywords

ANTIBIOTIC AGENT; DOXYCYCLINE; DOXYCYCLINUM; ESTROGEN; SODIUM CHLORIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE MARROW; BONE STRUCTURE; BONE TISSUE; CARTILAGE; CONTROLLED STUDY; DIAPHYSIS; DOSE RESPONSE; DRUG MECHANISM; EPIPHYSIS; ESTROGEN DEFICIENCY; FEMALE; FEMUR; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OSTEOID; OSTEOPENIA; OSTEOPOROSIS; OVARIECTOMY; PERIOSTEUM; RAT; RAT STRAIN; SYMPTOMATOLOGY; TIBIA; TRABECULAR BONE;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; DOXYCYCLINE; FEMALE; FEMUR; LUMBAR VERTEBRAE; OVARIECTOMY; RATS; RATS, WISTAR; TIBIA;

EID: 0043032815     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Attur M.G., Patel R.N., Patel P.D., Abramson S.B., Amin A.R.: Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide. J. Immunol., 1999, 162, 3160-3167.
2. Bain S., Ramamurthy N.S., Impeduglia T., Scolman S., Golub L.M., Rubin C.: Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats. Bone, 1997, 21, 147-153.
3. Beekman B., Verzijl N., de Roos J.A., Koopman J.L., TeKoppele J.M.: Doxycycline inhibits collagen synthesis by bovine chondrocytes cultured in alginate. Biochem. Biophys. Res. Commun., 1997, 237, 107-110.
4. Bettany J.T., Peet N.M., Wolowacz R.G., Skerry T.M., Grabowski P.S.: Tetracyclines induce apoptosis in osteoclasts. Bone, 2000, 27, 75-80.
5. Chang K.M., Ramamurthy N.S., McNamara T.F., Evans R.T., Klausen B., Murray P.A., Golub L.M.: Tetracyclines inhibit Porphyromonas gingivalis-induced alveolar bone loss in rats by a non-antimicrobial mechanism. J. Period. Res., 1994, 29, 242-249.
6. Chowdhury M.H., Moak S.A., Rifkin B.R., Greenwald R.A.: Effect of tetracyclines which have metalloproteinase inhibitory capacity on basal and heparin-stimulated bone resorption by chick osteoclasts. Agent. Action., 1993, 40, 124-128.
7. Ciancio S., Ashley R.: Safety and efficacy of sub-antimicrobial-dose doxycycline therapy in patients with adult periodontitis. Adv. Dent. Res., 1998, 12, 27-31.
8. Cummings G.R., Torabinejad M.: Effect of systemic doxycycline on alveolar bone loss after periradicular surgery. J. Endodont., 2000, 26, 325-327.
9. de Bri E., Lei W., Svensson O., Chowdhury M., Moak S.A., Greenwald R.A.: Effect of an inhibitor of matrix metalloproteinases on spontaneous osteoarthritis in guinea pigs. Adv. Dent. Res., 1998, 12, 82-85.
10. Engesaeter L.B., Skar A.G.: Effects of cloxacillin, doxycycline, fusidic acid and lincomycin on the mechanical properties of bone and skin in young rats. Acta Orthop. Scand., 1979, 50, 245-249.
11. Engesaeter L.B., Underdal T., Langeland N.: Effects of oxytetracycline on mineralization of bone in young rats. Acta Orthop. Scand., 1980, 51, 459-465.
12. Engesaeter L.B., Underdal T., Lyngaas K.H.N.: Effects of cloxacillin, doxycycline, fusidic acid and lincomycin on mineralization and solubility of collagen in young rats. Acta Orthop. Scand., 1980, 51, 467-470.
13. Folwarczna J., Janiec W., Firlus K., Kaczmarczyk-Sedlak I.: Effects of doxycycline on the development of bone damage caused by prednisolone in rats. Pol. J. Pharmacol., 1999, 51, 243-251.
14. Golub L.M, Lee H.M., Ryan M.E., Giannobile W.V., Payne J., Sorsa T.: Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 1998, 12, 12-26.
15. Golub L.M., Ramamurthy N.S., Kaneko H., Sasaki T., Rifkin B., McNamara T.F.: Tetracycline administration prevents diabetes-induced osteopenia in the rat: initial observations. Res. Commun. Chem. Pathol. Pharmacol., 1990, 68, 27-40.
16. Gomes B.C., Golub L.M., Ramamurthy N.S.: Tetracyclines inhibit parathyroid hormone-induced bone resorption in organ culture. Experientia, 1984, 40, 1273-1275.
17. Greenwald R.A., Golub L.M., Ramamurthy N.S., Chowdhury M., Moak S.A., Sorsa T.: In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation. Bone, 1998, 22, 33-38.
18. Greenwald R.A., Simonson B.G., Moak S.A., Rush S.W., Ramamurthy N.S., Laskin R.S., Golub L.M.: Inhibition of epiphyseal cartilage collagenase by tetracyclines in low phosphate rickets in rats. J. Orthop. Res., 1988, 6, 695-703.
19. Grevstad H.J., Bøe O.E.: Effect of doxycycline on surgically induced osteoclast recruitment in the rat. Eur. J. Oral Sci., 1995, 103, 156-159.
20. Karimbux N.Y., Ramamurthy N.S., Golub L.M., Nishimura I.: The expression of collagen I and XII mRNAs in Porphyromonas gingivalis-induced periodontitis in rats: the effect of doxycycline and chemically modified tetracycline. J. Periodontol., 1998, 69, 34-40.
21. Karna E., Pałka J., Wołczyński S.: Doxycycline-induced inhibition of prolidase activity in human skin fibroblasts and its involvement in impaired collagen biosynthesis. Eur. J. Pharmacol., 2001, 430, 25-31.
22. Klapisz-Wolikow M., Saffar J.L.: Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat. J. Cell. Physiol., 1996, 167, 359-368.
23. Langevitz; P., Livneh A., Bank I., Pras M.: Benefits and risks of minocycline in rheumatoid arthritis. Drug Safety, 2000, 22, 405-414.
24. Levy J., Ornoy A., Atkin I.: Influence of tetracycline on the calcification of epiphyseal rat cartilage. Transmission and scanning electron-microscopic studies. Acta Anat., 1980, 106, 360-369.
25. Manolagas S.C.: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Rev., 2000, 21, 115-137.
26. Pacifici R.: Cytokines, estrogen, and postmenopausal osteoporosis-the second decade. Endocrinology, 1998, 139, 2659-2661.
27. Parikka V, Lehenkari P., Sassi M.L., Halleen J., Risteli J., Härkönen P., Väänänen H.K.: Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology, 2001, 142, 5371-5378.
28. Peng Z.-Q., Väänänen H.K, Zhang H.X, Tuukkanen J.: Long-term effects of ovariectomy on the mechanical properties and chemical composition of rat bone. Bone, 1997, 20, 207-212.
29. Ramamurthy N., Bain S., Liang C.T., Barnes J., Llavaneras A., Liu Y, Puerner D., Strachan M.J., Golub L.M.: A combination of subtherapeutic doses of chemically modified doxycycline (CMT-8) and a bisphosphonate (clodronate) inhibits bone loss in the ovariectomized rat: a dynamic histomorphometric and gene expression study. Curr. Med. Chem., 2001, 8, 295-303.
30. Rifkin B.R., Vernillo A.T., Golub L.M.: Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically modified analogs. J. Periodontol., 1993, 64, 819-827.
31. Rifkin B.R., Vernillo A.T., Golub L.M., Ramamurthy N.S.: Modulation of bone resorption by tetracyclines. Ann. NY Acad. Sci., 1994, 732, 165-180.
32. Sasaki T., Kaneko H., Ramamurthy N.S., Golub L.M.: Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anat. Rec., 1991, 231, 25-34.
33. Sasaki T., Ohyori N., Debari K., Ramamurthy N.S., Golub L.M.: Effects of chemically modified tetracycline, CMT-8, on bone loss and osteoclast structure and function in osteoporotic states. Ann. NY Acad. Sci., 1999, 878, 347-360.
34. Sasaki T., Ramamurthy N.S., Golub L.M.: Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocin-induced diabetic rats: a quantitative autoradiographic study. Calcified Tissue Int., 1992, 50, 411-419.
35. Scarpellini F., Scarpellini L., Andreassi S., Cosmi E.V.: Doxycycline may inhibit postmenopausal bone damage. Preliminary observations. Ann. NY Acad. Sci., 1994, 732, 493-494.
36. Simmons D.J., Chang S.-L., Russell J.E., Grazman B., Webster D., Oloff C.: The effect of protracted tetracycline treatment on bone growth and maturation. Clin. Orthop., 1983, 180, 253-259.
37. Tanizawa T., Yamaguchi A., Uchiyama Y., Miyaura C., Ikeda T., Ejiri S., Nagal Y., Yamato H., Murayama H., Sato M., Nakamura T.: Reduction in bone formation and elevated bone resorption in ovariectomized rats with special reference to acute inflammation. Bone, 2000, 26, 43-53.
38. Tripp E.J., MacKay E.H.: Silver staining of bone prior to decalcification for quantitative determination of osteoid in sections. Stain Technol., 1972, 47, 129-131.
39. van der Bijl P., Pitigoi-Aron G.: Tetracyclines and calcified tissues. Ann. Dent., 1995, 54, 69-72.
40. van der Laan W., Molenaar E., Ronday K., Verheijen J., Breedveld F., Greenwald R., Dijkmans B., TeKoppele J.: Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial. J. Rheumatol., 2001, 28, 1967-1974.
41. Vernillo A.T., Rifkin B.R.: Effects of tetracyclines on bone metabolism. Adv. Dent. Res., 1998, 12, 56-62.
42. Williams S., Barnes J., Wakisaka A., Ogasa H., Liang C.T.: Treatment of osteoporosis with MMP inhibitors. Ann. NY Acad. Sci., 1999, 878, 191-200.
43. Williams S., Wakisaka A., Zeng Q.Q., Barnes J., Martin G., Wechter W.J., Liang C.T.: Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone, 1996, 19, 637-644.
44. Williams S., Wakisaka A., Zeng Q.Q., Barnes J., Seyedin S., Martin G., Wechter W.J., Liang C.T.: Effect of minocycline on osteoporosis. Adv. Dent. Res., 1998, 12, 71-75.